eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cystoid macular dystrophy |
| Symptom | |retinal vein occlusion |
| Sentences | 122 |
| PubMedID- 23483492 | Treatment of macular edema associated with retinal vein occlusion using sustained-release dexamethasone implants in a clinical setting. |
| PubMedID- 23179231 | Intravitreal bevacizumab has been adopted as a well-established treatment modality for the treatment of macular edema associated with branch retinal vein occlusion. |
| PubMedID- 26285577 | Conclusion: the possibility of an infrequent complication like macular hole should be considered for intravitreal ranibizumab for macular edema with branch retinal vein occlusion. |
| PubMedID- 25223207 | Subjects and methods: twenty seven eyes of 27 patients who had undergone vitrectomy for macular edema associated with branch retinal vein occlusion (brvo), proliferative diabetic retinopathy (pdr), macular hole (mh)/epiretinal membrane (erm) at toho university sakura medical center were studied. |
| PubMedID- 24876761 | Background: we report our findings in three cases of unilateral macular edema associated with retinal vein occlusion (rvo) that improved after successful treatment of systemic hypertension alone. |
| PubMedID- 19430731 | We report a case of a 69-year-old male patient who came to our attention for macular edema in hemiretinal vein occlusion. |
| PubMedID- 19956967 | Macular microcirculation before and after vitrectomy for macular edema with branch retinal vein occlusion. |
| PubMedID- 24741610 | It was approved by the fda for the treatment of neovascular amd, macular edema associated with retinal vein occlusion, and since 2012, it is approved for the treatment of dme . |
| PubMedID- 22095093 | Retinal sensitivity after resolution of the macular edema associated with retinal vein occlusion. |
| PubMedID- 24778755 | Branch retinal vein occlusion with sectoral cystoid macular edema in toxoplasmic chorioretinitis. |
| PubMedID- 25743778 | Intraocular pressure after intravitreal injection of dexamethasone implant for macular edema resulting from retinal vein occlusion. |
| PubMedID- 22392532 | It is an fda-approved intravitreal therapy for the treatment of age-related macular degeneration and macular edema associated with retinal vein occlusion . |
| PubMedID- 24492507 | the authors recommend the use of a single injection of ranibizumab followed by a single session of laser photocoagulation to treat macular edema associated with branch retinal vein occlusion. |
| PubMedID- 20653482 | Purpose: to evaluate secondary ocular hypertension after intravitreal injection of triamcinolone acetonide (ivta) with 2 mg/0.05 ml or 4 mg/0.1 ml for macular edema associated with retinal vein occlusion (rvo). |
| PubMedID- 20148661 | Intravitreal bevacizumab (avastin) in the treatment of macular edema associated with perfused retinal vein occlusion. |
| PubMedID- 22823029 | Bevacizumab, a monoclonal antibody against vascular endothelial growth factor (vegf), is widely used for the treatment of macular edema associated with central retinal vein occlusion (crvo). |
| PubMedID- 20453544 | The outcome of vitrectomy for macular edema was examined in patients with central retinal vein occlusion (crvo), as well as whether vascular endothelial growth factor (vegf) and interleukin-6 (il-6) levels in vitreous fluid influence the visual prognosis and macular edema. |
| PubMedID- 23160823 | The objective of this study is to evaluate functional and morphological changes of the macula after pars plana vitrectomy (ppv) for macular edema with branch retinal vein occlusion (brvo). |
| PubMedID- 24526927 | The ozurdex dexamethasone-sustained delivery implant has been approved by the united states food and drug administration (fda) for the treatment of macular edema associated with retinal vein occlusion (rvo) and for noninfectious posterior uveitis. |
| PubMedID- 23984139 | Dexamethasone implant (ozurdex) is approved for eyes with posterior uveitis and macular edema associated with retinal vein occlusions . |
| PubMedID- 26418442 | Evaluation of multiple dexamethasone intravitreal implants in patients with macular edema associated with retinal vein occlusion. |
| PubMedID- 25885285 | Background: dexamethasone intravitreal implant (dex implant) is a sustained-release biodegradable implant approved for treatment of macular edema associated with retinal vein occlusion (rvo). |